Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 13.02%2.71M | 22.44%2.84M | 26.73%3.34M | -5.34%10.65M | -1.50%3.29M | 21.77%2.4M | -4.94%2.32M | -24.61%2.63M | -0.69%11.25M | 3.15%3.34M |
| Net income from continuing operations | -77.96%2.86M | 84.87%-1.35M | 707.33%10.18M | -61.02%7.1M | -58.84%1.79M | 327.10%12.97M | -248.34%-8.92M | -73.89%1.26M | 380.61%18.22M | 146.66%4.34M |
| Operating gains losses | 98.68%-144.49K | -64.19%4.13M | -728.09%-7.64M | 139.11%2.89M | 165.09%1.06M | -2,684.21%-10.91M | 455.11%11.53M | 157.06%1.22M | -141.93%-7.4M | -113.30%-1.63M |
| Remuneration paid in stock | -22.21%243.15K | 132.76%187.47K | 50.88%369.93K | 75.92%692.21K | -52.91%53.92K | 221.16%312.57K | -28.45%80.55K | 254.88%245.18K | -34.70%393.48K | 19.97%114.5K |
| Deferred tax | ---- | ---- | ---- | -1,696.78%-97.32K | ---- | ---- | ---- | ---- | 307.38%6.1K | ---- |
| Other non cashItems | 6.62%1.7M | 2.51%1.87M | -1.59%1.64M | 2.84%6.82M | -5.39%1.73M | -0.53%1.6M | 1.79%1.82M | 18.81%1.67M | 29.06%6.63M | 10.45%1.83M |
| Change In working capital | -447.48%-186.64K | 43.71%-255.72K | 1,528.59%484.98K | -121.47%-46.84K | -2.37%387.65K | 108.06%53.71K | 13.21%-454.25K | -103.36%-33.95K | 2.31%218.15K | 49.86%397.06K |
| -Change in payables and accrued expense | -160.83%-42.61K | 67.28%-24.94K | 139.28%129.82K | -282.48%-367.95K | -112.96%-31.29K | 168.08%70.04K | -149.99%-76.22K | -270.10%-330.48K | -59.67%201.63K | 4.81%241.33K |
| -Change in other current assets | -66.31%88.24K | 90.11%-29.6K | -131.93%-52.52K | 48,614.00%294.48K | 1,925.21%167.34K | 201.55%261.91K | 2.49%-299.27K | -71.31%164.5K | 99.89%-607 | 94.35%-9.17K |
| -Change in other current liabilities | 16.52%-232.27K | -155.44%-201.18K | 208.78%407.68K | 55.50%26.63K | 52.59%251.6K | 8.98%-278.25K | 78.65%-78.76K | -74.94%132.03K | -93.63%17.12K | -16.32%164.89K |
| Interest paid (cash flow from operating activities) | -8.59%-1.76M | 0.27%-1.74M | 1.47%-1.7M | 1.60%-6.71M | 5.49%-1.63M | 5.22%-1.62M | -2.38%-1.74M | -2.05%-1.72M | -18.27%-6.82M | -2.15%-1.72M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 13.02%2.71M | 22.44%2.84M | 26.73%3.34M | -5.34%10.65M | -1.50%3.29M | 21.77%2.4M | -4.94%2.32M | -24.61%2.63M | -0.69%11.25M | 3.15%3.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -102.50%-263.53K | -97.70%41.75K | -3,950.11%-11.74M | 37.03%3.72M | -1,755.86%-8.96M | 1,536.26%10.56M | 62.64%1.82M | -25.80%305.04K | 106.53%2.71M | 237.17%541.1K |
| Net business purchase and sale | --0 | --0 | ---- | 16.90%-220K | 100.00%-1 | ---140K | 54.87%-80K | ---- | 52.40%-264.75K | 20.45%-87.5K |
| Net investment property transactions | -101.68%-176.28K | -111.65%-148.5K | -22,565.37%-12.57M | -0.08%2.66M | -714.15%-9.07M | 1,556.01%10.51M | 10.99%1.27M | 90.72%-55.46K | 106.03%2.66M | 528.42%1.48M |
| Dividends received (cash flow from investment activities) | 21.43%12.75K | -82.49%90.25K | 6,423.19%685K | -21.41%647K | -38.35%110.5K | 0.00%10.5K | 221.18%515.5K | -97.78%10.5K | -70.88%823.25K | 82.91%179.25K |
| Net other investing changes | -156.85%-100K | -4.76%100K | -60.00%140K | 224.26%630.9K | --0 | --175.9K | 771.06%105K | -34.64%350K | -269.74%-507.71K | -2,622.84%-1.03M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -102.50%-263.53K | -97.70%41.75K | -3,950.11%-11.74M | 37.03%3.72M | -1,755.86%-8.96M | 1,536.26%10.56M | 62.64%1.82M | -25.80%305.04K | 106.53%2.71M | 237.17%541.1K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 78.82%-2.81M | 22.66%-3.2M | 428.77%9.01M | -9.82%-14.48M | 246.80%5.64M | -332.08%-13.24M | -35.65%-4.13M | 15.16%-2.74M | -144.19%-13.18M | -17.04%-3.84M |
| Net issuance payments of debt | 91.26%-1M | 39.82%-1.42M | 1,211.41%10.79M | -31.91%-7.39M | 457.98%7.41M | -882.27%-11.47M | -171.09%-2.36M | 34.95%-970.41K | -115.92%-5.6M | -35.01%-2.07M |
| Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | -130.09%-488.61K | --0 |
| Cash dividends paid | -1.64%-1.8M | -0.17%-1.78M | -0.16%-1.77M | 0.05%-7.09M | -0.16%-1.77M | -0.16%-1.77M | 0.17%-1.77M | 0.36%-1.77M | -1.84%-7.1M | -1.27%-1.77M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 78.82%-2.81M | 22.66%-3.2M | 428.77%9.01M | -9.82%-14.48M | 246.80%5.64M | -332.08%-13.24M | -35.65%-4.13M | 15.16%-2.74M | -144.19%-13.18M | -17.04%-3.84M |
| Net cash flow | ||||||||||
| Beginning cash position | -1.43%1.17M | 25.21%1.48M | -10.98%879.28K | 380.80%987.72K | -3.91%906.86K | -14.49%1.19M | 34.84%1.19M | 380.80%987.72K | -66.14%205.43K | 47.48%943.78K |
| Current changes in cash | -25.37%-353.98K | -8,606.73%-312.11K | 205.89%605.09K | -113.86%-108.45K | -162.76%-27.58K | 36.83%-282.35K | -99.28%3.67K | -70.64%197.81K | 294.94%782.29K | 110.11%43.94K |
| End cash Position | -9.77%818.28K | -1.43%1.17M | 25.21%1.48M | -10.98%879.28K | -10.98%879.28K | -3.91%906.86K | -14.49%1.19M | 34.84%1.19M | 380.80%987.72K | 380.80%987.72K |
| Free cash from | 13.02%2.71M | 22.44%2.84M | 26.73%3.34M | -5.34%10.65M | -1.50%3.29M | 21.77%2.4M | -4.94%2.32M | -24.61%2.63M | -0.69%11.25M | 3.15%3.34M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.